- About Us
- Advertise
- Editorial
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Pharmaceutical Commerce - April 2010
New ethics code draws clear line between physicians and drug companies
April 30, 2010
No specific guidelines included on how restrictive financial interactions should be
FDA puts a spotlight on cargo theft of life sciences products
April 29, 2010
FDA-run website will provide a single point of reference
New study sets benchmark for post-marketing surveillance process
April 27, 2010
Gaps found in gray areas like adverse events reported on blogs and interactive web events
Comparative effectiveness research gets boost with healthcare overhaul law
April 26, 2010
PPACA provides $3 billion in funding and creates new Patient-Centered Outcomes Research Institute
Global pharma growth will be 5-8% annually through 2014, predicts IMS Health
April 22, 2010
‘Pharmerging’ markets will provide half the boost to 2014’s $1.1-trillion market
ValueCentric offers a New Product Launch service leveraging CVS Caremark trade data
April 22, 2010
Service builds on ValueCentrics’ ValueTrak channel-data tracking capability
New United BioSource partnership steps up expertise across Asia-Pacific markets
April 22, 2010
Singapore-based Clearstate will help UBC clients navigate complex reimbursements policies
NanoGuardian one step closer to delivering early-warning anti-counterfeiting system
April 21, 2010
Altegrity Risk International named security partner in Closed-Loop Protection Program
Diplomat Specialty Pharmacy poised for growth in Michigan
April 21, 2010
Specialty pharmacy wins $61.5M in tax credits and $14M in grants for 1,000-plus jobs
Global pharma growth will be 5-8% annually through 2014, predicts IMS Health
April 20, 2010
‘Pharmerging’ markets will provide half the boost to 2014’s $1.1-trillion market
Cancer drug Avastin tops forecast for 2014's top-selling drugs worldwide
April 15, 2010
Blockbusters Lipitor and Plavix disappear from list due to patent expirations
Prime Therapeutics identifies factors influencing drug adherence
April 15, 2010
90-day supplies and lower out-of-pocket expenses positively impact compliance
FDA Approves Harder-to-Abuse OxyContin Formulation
April 14, 2010
Reformulated drug is a ‘step in the right direction,’ says FDA director
Time Is Running Out on Unused Stocks of H1N1 Vaccine
April 13, 2010
CDC to release action plan for dealing with unused or expired swine flu vaccine
Follow the Money... Where Healthcare Policy is Headed
April 10, 2010
CMS will be changing reimbursement practices regardless of how healthcare reform plays out
AstraZeneca's Principles for Product-Related Online Communications
April 10, 2010
Industry anticipates meaningful guidance from FDA on use of social media
How Well Can Biopharma Protect Itself Against Theft?
April 10, 2010
Monetizing Intellectual Property: Royalties, Revenues and Alternative Sources of Capital
April 10, 2010
Investment funds have developed an interest in trading capital for royalties on drug commercializations
Look for Flexibility In Your CRM or SFA System
April 10, 2010
Business, regulatory and technological conditions are constantly changing. Will your CRM/SFA system be flexible enough to keep up?
True Software-as-a-Service (SaaS) Transforms Sales Automation Systems to Make Upgrades Painless
April 10, 2010
Multi-tenant sales-force automation (SFA) systems are coping with an increasingly complex regulatory environment
Leveraging the EHR to Advance Clinical Research
April 10, 2010
Converging the processes and data from EHRs and from the electronic data-capture (EDC) of the clinical research environment could change the paradigm of drug development and safety
Injectable-Drug Market Continues Moving Toward Plastics and Prefilled Syringes
April 10, 2010
Parenteral (injectable) drugs gain user acceptance even as biotech brings more of them onto the market
Get Ready for Pharma 3.0, Says Ernst & Young in Its Annual Progressions Report
April 10, 2010
The growth of healthcare business is attracting many new players to the pharmaceutical arena, challenging pharma’s relationships with patients
Industry Sets Its Social-Media Regulatory Position With DDMAC
April 10, 2010
PhRMA pushes for an FDA ‘universal symbol’ of approved content, and seeks latitude in communications in online forums
Global Growth Will Accelerate in 'Pharmerging' Countries, Says IMS Health
April 10, 2010
Big Pharma is not yet deeply enough invested in faster-growing markets outside the developed economies
SupplyScape, reborn as TraceLink, is back with the
April 09, 2010
Pedigree-pioneering team resurfaces with cloud-based collaborative platform
FDA's DDMAC Takes Another Stab at Enforcing Fair Balance in Drug Advertising
April 09, 2010
Agency strives to balance risks and benefits in how drugs are presented in direct-to-consumer (DTC) campaigns
What the iPad Means for Pharma
April 08, 2010
New Apple gadget could help usher in an era of medical applications fully integrated into a healthcare professional’s day-to-day life
US Prescription Sales Grew 5.1% in 2009 to $300.3 billion, Estimates IMS Health
April 07, 2010
Generics are now 75% of dispensed prescriptions, with generics up 5.9% in 2009 and branded products down 7.6%
Public Thinks Less of Pharmaceutical Industry in 2009
April 06, 2010
In latest Harris Interactive study, reputation of the pharmaceutical industry drops, but still fares better than some sectors
Mega-Mergers Affect Real Estate Landscape for Pharma
April 02, 2010